Back

The association between sex and body size and stroke risk and survival in patients with atrial fibrillation - an analysis of 71,589 patients from the COMBINE-AF study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Scores and sudden death in women Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Julia Aulin

Uppsala University, Uppsala (Sweden)

5 More presentations in this session

Presentation thumbnail
Gender-specific predictors of all-cause of death in symptomatic severe aortic stenosis with preserved ejection fraction.
Doctor S. Avakian (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Association between Life's Essential 8 scores with 5-year all-cause and cardiovascular mortality among postmenopausal females: based on a cohort study
Doctor X. Li (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Sex differences in acute myocardial infarction: clinical characteristics and angiographic findings in a cohort
Doctor H. Ramirez Yanez (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Racial and gender disparities in sudden cardiac death vs. acute myocardial infarction mortality: a CDC WONDER analysis
Doctor Q. Abdul (Dartford, GB)
Abstract Slides Video
Presentation thumbnail
Increased risk of cardiovascular disease in women with endometriosis: a systematic review and meta-analysis
Doctor P. Sajnani (Plymouth, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Scores and sudden death in women

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of differences in body mass index, body surface area and lean body mass on clinical outcomes in patients with atrial fibrillation receiving edoxaban: 4-year follow-up data from ETNA-AF-Europe
thumbnail
Congress Presentation
Comparison of CHA2DS2-VA and CHA2DS2-VASc scores for predicting residual risk of stroke and adverse outcomes in anticoagulated patients with atrial fibrillation: a report from a European registry
thumbnail
Congress Presentation
Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources